Monday 19 November 2018
Home      All news      Contact us      Philipino
Channel News Asia - 29 days ago

Roche takes on Loxo, Bayer in gene-defined cancer class

Roche s entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that can only be identified via genetic profiling, as the Swiss drugmaker challenges an alliance of Bayer and Loxo Oncology in a new targeted treatment area.

Related news

Latest News
Hashtags:   

Roche

 | 

takes

 | 

Bayer

 | 

defined

 | 

cancer

 | 

class

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources